Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshito Akagi

Showing results (181-190 of 261) with videos related to

Pageof 27
Sort By:
Cancer Chemotherapy and Pharmacology|July 30, 2016
Multicenter phase II study of combination therapy with cetuximab and S-1 in patients with KRAS exon 2 wild-type unresectable colorectal cancer previously treated with irinotecan, oxaliplatin, and fluoropyrimidines (KSCC 0901 study)Takao Takahashi, Yasunori Emi, Eiji Oki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2021
[A Case Report of Duodenal Ampullary Carcinoma with Annular Pancreas]Toshihiro Sato, Hisamune Sakai, Daisuke Muroya, et al.
Case Reports in Gastroenterology|April 1, 2021
Hepatic Epithelioid Hemangioendothelioma Presenting Synchronously with Hepatocellular CarcinomaHiroki Kanno, Toshihiro Sato, Ryuta Midorikawa, et al.
Cancer Science|May 26, 2020
Differences in the immunosurveillance pattern associated with DNA mismatch repair status between right-sided and left-sided colorectal cancerHiroki Kanno, Hiroaki Miyoshi, Naohiro Yoshida, et al.
Anticancer Research|June 20, 2013
Virchow lymph node metastatic recurrence of sigmoid colon cancer with severe lymph node metastases successfully treated using systemic chemotherapy combined with radiotherapyTakafumi Ohchi, Yoshito Akagi, Tetsushi Kinugasa, et al.
Molecular Cancer Therapeutics|December 28, 2019
Targeting Phosphorylation of Y-Box-Binding Protein YBX1 by TAS0612 and Everolimus in Overcoming Antiestrogen ResistanceTomohiro Shibata, Kosuke Watari, Akihiko Kawahara, et al.
Anticancer Research|August 2, 2019
Sarcomatous Component in Pancreatic Adenosquamous Carcinoma: A Clinicopathological Series of 7 CasesShinichi Taniwaki, Toru Hisaka, Hisamune Sakai, et al.
Anticancer Research|July 31, 2014
Minichromosome maintenance protein 7 is a risk factor for recurrence in patients with Dukes C colorectal cancerYoshiaki Ishibashi, Tetsushi Kinugasa, Yoshito Akagi, et al.
International Journal of Clinical Oncology|May 8, 2019
Skeletal muscle loss during systemic chemotherapy for colorectal cancer indicates treatment response: a pooled analysis of a multicenter clinical trial (KSCC 1605-A)Shun Sasaki, Eiji Oki, Hiroshi Saeki, et al.
Anticancer Research|July 27, 2022
Predictive and Prognostic Value of SUOX Expression in Pancreatic Ductal AdenocarcinomaYoshiki Naito, Jun Akiba, Yoshinao Kinjo, et al.
Pageof 27

Showing results (181-190 of 261) with videos related to

Sort By:
Pageof 27
Cancer Chemotherapy and Pharmacology|July 30, 2016
Multicenter phase II study of combination therapy with cetuximab and S-1 in patients with KRAS exon 2 wild-type unresectable colorectal cancer previously treated with irinotecan, oxaliplatin, and fluoropyrimidines (KSCC 0901 study)Takao Takahashi, Yasunori Emi, Eiji Oki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2021
[A Case Report of Duodenal Ampullary Carcinoma with Annular Pancreas]Toshihiro Sato, Hisamune Sakai, Daisuke Muroya, et al.
Case Reports in Gastroenterology|April 1, 2021
Hepatic Epithelioid Hemangioendothelioma Presenting Synchronously with Hepatocellular CarcinomaHiroki Kanno, Toshihiro Sato, Ryuta Midorikawa, et al.
Cancer Science|May 26, 2020
Differences in the immunosurveillance pattern associated with DNA mismatch repair status between right-sided and left-sided colorectal cancerHiroki Kanno, Hiroaki Miyoshi, Naohiro Yoshida, et al.
Anticancer Research|June 20, 2013
Virchow lymph node metastatic recurrence of sigmoid colon cancer with severe lymph node metastases successfully treated using systemic chemotherapy combined with radiotherapyTakafumi Ohchi, Yoshito Akagi, Tetsushi Kinugasa, et al.
Molecular Cancer Therapeutics|December 28, 2019
Targeting Phosphorylation of Y-Box-Binding Protein YBX1 by TAS0612 and Everolimus in Overcoming Antiestrogen ResistanceTomohiro Shibata, Kosuke Watari, Akihiko Kawahara, et al.
Anticancer Research|August 2, 2019
Sarcomatous Component in Pancreatic Adenosquamous Carcinoma: A Clinicopathological Series of 7 CasesShinichi Taniwaki, Toru Hisaka, Hisamune Sakai, et al.
Anticancer Research|July 31, 2014
Minichromosome maintenance protein 7 is a risk factor for recurrence in patients with Dukes C colorectal cancerYoshiaki Ishibashi, Tetsushi Kinugasa, Yoshito Akagi, et al.
International Journal of Clinical Oncology|May 8, 2019
Skeletal muscle loss during systemic chemotherapy for colorectal cancer indicates treatment response: a pooled analysis of a multicenter clinical trial (KSCC 1605-A)Shun Sasaki, Eiji Oki, Hiroshi Saeki, et al.
Anticancer Research|July 27, 2022
Predictive and Prognostic Value of SUOX Expression in Pancreatic Ductal AdenocarcinomaYoshiki Naito, Jun Akiba, Yoshinao Kinjo, et al.
Pageof 27